MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

167.44 -3.89 (-2.27%)
Streaming Delayed Price Updated: 1:32 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,052,227
Open 170.67
Bid (Size) 167.41 (100)
Ask (Size) 167.48 (500)
Prev. Close 171.33
Today's Range 166.72 - 170.78
52wk Range 116.49 - 179.64
Shares Outstanding N/A
Dividend Yield 0.15%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
2 Ways to Play the Big Pharma Patent Cliff ↗
With hundreds of billions in sales on the line for drugs that will lose their patent exclusivity in the coming years, two biotech ETFs can help capitalize. 
Via MarketBeat
Topics ETFs Intellectual Property
News headline image
Corcept Therapeutics Outperforms: How a Surprise FDA Approval Ignited a Late-March Rally
In a month characterized by macroeconomic headwinds and a broader cooling of the biotechnology sector, Corcept Therapeutics (NASDAQ: CORT) has emerged as a definitive outlier. While the S&P Biotech ETF... 
Via MarketMinute
Topics ETFs Intellectual Property Stocks

Performance

YTD
-0.9%
-0.9%
1 Month
-4.8%
-4.8%
3 Month
-1.9%
-1.9%
6 Month
+2.5%
+2.5%
1 Year
+43.2%
+43.2%

More News

Read More
News headline image
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Derivatives ETFs Regulatory Compliance
PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? ↗
Via Stocktwits
News headline image
QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure ↗
Via Stocktwits
Topics Initial Public Offering
News headline image
QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 ↗
Via Stocktwits
News headline image
Why Did CRMD Stock Tumble Over 11% Today? ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Why Did BTAI Stock Surge 20% In Pre-Market Today? ↗
Via Stocktwits
News headline image
Why Did CDXS Stock Jump 7% Today? ↗
Via Stocktwits
News headline image
AARD Stock Slumps 54% Pre-Market – Here’s Why Analysts Are Not ‘Comfortable’ With The Suspension Of A Key Phase 3 Trial ↗
Via Stocktwits
News headline image
AUPH Stock Gains On Aurinia Pharma’s Q4 Beat, But 2026 Guidance Misses Estimates ↗
Via Stocktwits
News headline image
VIR Stock Surges 60% Pre-Market Today – Analysts Cheer Strong Cancer Data, Astellas Partnership ↗
Via Stocktwits
News headline image
ImmunityBio’s Q4 Revenue Gets A Lift From ANKTIVA Sales – IBRX Stock Gains 1% Pre-Market ↗
Via Stocktwits
News headline image
Why Did ACLX Stock Surge 80% In Pre-Market Today? ↗
Via Stocktwits
News headline image
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition ↗
Via Stocktwits
News headline image
CMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial ↗
Via Stocktwits
News headline image
CMPS Stock Jumps 22% Pre-Market As Compass Sets Timeline For New Phase 3 Depression Trial Results ↗
Via Stocktwits
News headline image
HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge ↗
Via Stocktwits
News headline image
Why Is ALVO Stock Rising Pre-Market Today? ↗
Via Stocktwits
News headline image
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
Via MarketMinute
Topics ETFs Government Initial Public Offering
News headline image
Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock ↗
Via Stocktwits
News headline image
Why Did SER Stock Surge Over 70% In Pre-Market Today? ↗
Via Stocktwits
News headline image
This Wealth Manager Just Dumped Its Entire $3.5 Million Stake in the iShares Biotech ETF ↗
Via The Motley Fool
Topics Derivatives ETFs Regulatory Compliance
News headline image
2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗
Via The Motley Fool
Topics ETFs Intellectual Property World Trade
News headline image
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
Via MarketMinute
Topics Artificial Intelligence Economy

Frequently Asked Questions

Is iShares Biotechnology ETF publicly traded?
Yes, iShares Biotechnology ETF is publicly traded.
What exchange does iShares Biotechnology ETF trade on?
iShares Biotechnology ETF trades on the Nasdaq Stock Market
What is the ticker symbol for iShares Biotechnology ETF?
The ticker symbol for iShares Biotechnology ETF is IBB on the Nasdaq Stock Market
What is the current price of iShares Biotechnology ETF?
The current price of iShares Biotechnology ETF is 167.44
When was iShares Biotechnology ETF last traded?
The last trade of iShares Biotechnology ETF was at 05/15/26 01:32 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story